Thomas Edward Hamilton - Net Worth and Insider Trading
Thomas Edward Hamilton Net Worth
The estimated net worth of Thomas Edward Hamilton is at least $5 Million dollars as of 2024-12-26. Thomas Edward Hamilton is the Director of Larimar Therapeutics Inc and owns about 724,231 shares of Larimar Therapeutics Inc (LRMR) stock worth over $3 Million. Thomas Edward Hamilton is also the Director of Annaly Capital Management Inc and owns about 135,000 shares of Annaly Capital Management Inc (NLY) stock worth over $3 Million. Details can be seen in Thomas Edward Hamilton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Edward Hamilton has not made any transactions after 2024-02-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Edward Hamilton
Thomas Edward Hamilton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Edward Hamilton owns 2 companies in total, including Larimar Therapeutics Inc (LRMR) , and Annaly Capital Management Inc (NLY) .
Click here to see the complete history of Thomas Edward Hamilton’s form 4 insider trades.
Insider Ownership Summary of Thomas Edward Hamilton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2024-02-16 | director |
| NLY | Annaly Capital Management Inc | 2020-05-15 | director |
Thomas Edward Hamilton Latest Holdings Summary
Thomas Edward Hamilton currently owns a total of 2 stocks. Among these stocks, Thomas Edward Hamilton owns 724,231 shares of Larimar Therapeutics Inc (LRMR) as of February 16, 2024, with a value of $3 Million and a weighting of 52.79%. Thomas Edward Hamilton also owns 135,000 shares of Annaly Capital Management Inc (NLY) as of May 15, 2020, with a value of $3 Million and a weighting of 47.21%.
Latest Holdings of Thomas Edward Hamilton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics Inc | 2024-02-16 | 724,231 | 3.96 | 2,870,924 |
| NLY | Annaly Capital Management Inc | 2020-05-15 | 135,000 | 19.02 | 2,567,700 |
Holding Weightings of Thomas Edward Hamilton
Thomas Edward Hamilton Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Edward Hamilton has made a total of 2 transactions in Larimar Therapeutics Inc (LRMR) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Larimar Therapeutics Inc is the acquisition of 57,208 shares on February 16, 2024, which cost Thomas Edward Hamilton around $499,998.
According to the SEC Form 4 filings, Thomas Edward Hamilton has made a total of 1 transactions in Annaly Capital Management Inc (NLY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Annaly Capital Management Inc is the acquisition of 50,000 shares on May 15, 2020, which cost Thomas Edward Hamilton around $1 Million.
Insider Trading History of Thomas Edward Hamilton
- 1
Thomas Edward Hamilton Trading Performance
GuruFocus tracks the stock performance after each of Thomas Edward Hamilton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Edward Hamilton is 5.76%. GuruFocus also compares Thomas Edward Hamilton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Edward Hamilton within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Edward Hamilton's insider trading performs compared to the benchmark.
Performance of Thomas Edward Hamilton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.77 | | | | | |
| Relative Return to S&P 500(%) | -5.49 | | | | | |
Thomas Edward Hamilton Ownership Network
Thomas Edward Hamilton Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Thomas Edward Hamilton is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Thomas Edward Hamilton made 1 insider transaction in Larimar Therapeutics Inc (LRMR) with a net purchase of 57,208. Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Gopi Shankar , and a net purchase of 2,000 shares made by Frank E Thomas .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,354,825 shares were bought by its insiders, resulting in a net purchase of 4,354,825 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Thomas Edward Hamilton Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Edward Hamilton. You might contact Thomas Edward Hamilton via mailing address: 211 Stuyvesant Ave, Rye Ny 10580.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
